Karyopharm Therapeutics (KPTI) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free KPTI Stock Alerts $1.06 -0.03 (-2.75%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKaryopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meetingprnewswire.com - April 24 at 4:01 PMKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 20 at 4:18 AMKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - April 1 at 4:05 PMKPTI Apr 2024 5.000 callfinance.yahoo.com - March 15 at 11:50 PMKPTI Apr 2024 1.500 putfinance.yahoo.com - March 15 at 11:50 PMOnco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO ® (selinexor)businesswire.com - March 14 at 9:46 AMKaryopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferencesfinance.yahoo.com - March 6 at 5:48 PMAnalysts Offer Insights on Healthcare Companies: Karyopharm Therapeutics (KPTI) and Siemens Healthineers AG (OtherSEMHF)markets.businessinsider.com - March 5 at 8:07 AMInsider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...finance.yahoo.com - March 5 at 1:39 AMKaryopharm Therapeutics Inc. (KPTI) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 5:21 PMKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - March 1 at 4:05 PMKaryopharm Therapeutics (NASDAQ:KPTI) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPSmarketbeat.com - March 1 at 3:57 PMKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 1 at 1:09 PMKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Recommendation of "Moderate Buy" by Analystsmarketbeat.com - March 1 at 9:22 AMBrokers Offer Predictions for Karyopharm Therapeutics Inc.'s FY2025 Earnings (NASDAQ:KPTI)marketbeat.com - March 1 at 8:45 AMKaryopharm Therapeutics (NASDAQ:KPTI) PT Lowered to $8.00 at HC Wainwrightmarketbeat.com - March 1 at 8:29 AMKaryopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcriptfool.com - February 29 at 10:56 PMQ4 2023 Karyopharm Therapeutics Inc Earnings Callfinance.yahoo.com - February 29 at 10:56 PMKaryopharm Therapeutics Inc.: Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progressfinanznachrichten.de - February 29 at 12:52 PMKaryopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08Mmsn.com - February 29 at 12:52 PMKaryopharm Therapeutics Inc. Q4 Loss misses estimatesmarkets.businessinsider.com - February 29 at 12:52 PMKaryopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progressfinance.yahoo.com - February 29 at 7:51 AMKaryopharm Therapeutics's Earnings: A Previewbenzinga.com - February 28 at 4:09 PMKPTI Mar 2024 1.000 putfinance.yahoo.com - February 27 at 11:29 PMAnalysts Offer Insights on Healthcare Companies: FibroGen (FGEN), Karyopharm Therapeutics (KPTI) and Day One Biopharmaceuticals (DAWN)markets.businessinsider.com - February 27 at 8:27 AMKPTI Mar 2024 1.500 callca.finance.yahoo.com - February 25 at 1:50 PM7 Biotech Penny Stocks on the Verge of Clinical Trial Victoryinvestorplace.com - February 25 at 1:37 PMKaryopharm Therapeutics (KPTI) to Release Quarterly Earnings on Thursdaymarketbeat.com - February 23 at 9:50 AMKaryopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Callsbenzinga.com - February 23 at 7:49 AMKaryopharm Therapeutics Stock (NASDAQ:KPTI) Insider Tradesbenzinga.com - February 23 at 7:49 AMKaryopharm Therapeutics Stock (NASDAQ:KPTI), Short Interest Reportbenzinga.com - February 22 at 1:50 PMKaryopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024finance.yahoo.com - February 22 at 7:55 AMKaryopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024prnewswire.com - February 22 at 7:00 AMArdelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?finance.yahoo.com - February 15 at 12:53 PMKaryopharm Therapeutics Inc (KPTI)investing.com - February 10 at 8:50 PMKaryopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though investors from three years ago are still down 90%finance.yahoo.com - February 7 at 10:47 AMKaryopharm Therapeutics Sees Unusually High Options Volume (NASDAQ:KPTI)marketbeat.com - February 6 at 11:16 AMMorphoSys jumps amid report Novartis in takeover talks; Karyopharm surges in sympathy (update)msn.com - February 5 at 11:19 PMKaryopharm: Approaching The Bottom Ahead Of Earnings And Topline Data (Rating Upgrade)seekingalpha.com - February 5 at 6:18 PMKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - February 1 at 6:39 PMPiper Sandler Reaffirms Their Buy Rating on Karyopharm Therapeutics (KPTI)markets.businessinsider.com - January 10 at 10:22 AMKaryopharm Therapeutics Inc.: Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectivesfinanznachrichten.de - January 8 at 3:05 PMKaryopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectivesfinance.yahoo.com - January 8 at 10:05 AMKaryopharm Therapeutics Inc.: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - January 3 at 9:22 AMKaryopharm to Present at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 9:22 AMKaryopharm Therapeutics Inc KPTImorningstar.com - December 15 at 8:27 PMKaryopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)finance.yahoo.com - December 10 at 10:23 PMGreat week for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) institutional investors after losing 84% over the previous yearfinance.yahoo.com - December 6 at 7:35 AMKaryopharm Therapeutics; Promising Potential With 3 Ongoing Phase 3 Studies But Riskyseekingalpha.com - November 29 at 9:01 PMThe Petri Dish: Concerns mar Verve data; Alnylam-Roche drug shows promisebizjournals.com - November 16 at 9:12 AM Get Karyopharm Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). KPTI Media Mentions By Week KPTI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KPTI News Sentiment▼0.110.37▲Average Medical News Sentiment KPTI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KPTI Articles This Week▼32▲KPTI Articles Average Week Get Karyopharm Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eliem Therapeutics News Today CytomX Therapeutics News Today Vistagen Therapeutics News Today FibroGen News Today Nuvectis Pharma News Today Repare Therapeutics News Today OptiNose News Today Sagimet Biosciences News Today Citius Pharmaceuticals News Today Coya Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KPTI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & CompanyThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
